1. Short title This Act may be cited as the ACES Act . 2. National Academies study on prevalence and mortality of cancer among individuals who served as active duty aircrew in the Armed Forces (a) In general The Secretary of Veterans Affairs shall enter into an agreement with the National Academies of Sciences, Engineering, and Medicine (in this section referred to as the National Academies ), under which the National Academies shall conduct a study on the prevalence and mortality of cancers among covered individuals. (b) Study The study required under subsection (a) shall— (1) identify exposures associated with military occupations of covered individuals, including relating to chemicals, compounds, agents, and other phenomena; (2) review the literature to determine associations between exposures referred to in paragraph (1) and the incidence or prevalence of overall cancer morbidity, overall cancer mortality, and increased incidence or prevalence of— (A) brain cancer; (B) colon and rectal cancers; (C) kidney cancer; (D) lung cancer; (E) melanoma skin cancer; (F) non-Hodgkin lymphoma; (G) pancreatic cancer; (H) prostate cancer; (I) testiscular cancer; (J) thyroid cancer; (K) urinary bladder cancer; and (L) other cancers as determined appropriate by the Secretary of Veterans Affairs, in consultation with the National Academies; and (3) determine, to the extent possible, the prevalence of and mortality from the cancers specified in paragraph (2) among covered individuals by using available sources of data, which may include— (A) health care and other administrative databases of the Department of Veterans Affairs, the Department of Defense, and the individual Services, respectively; (B) the national death index maintained by the National Center for Health Statistics of the Centers for Disease Control and Prevention; and (C) the study conducted under section 750 of the William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021 ( Public Law 116–283